PIK3CD and breast carcinoma: GDC-0077, a PI3Kα inhibitor more selective towards mutant PI3K than wild-type PI3K, was found to induce proteasomal degradation of mutant PI3K, and caused tumor regression in PIK3CA-mutant breast cancer xenografts [115,116].